Extrawell Pharmaceutical Holdings Limited (HKG:0858)
Hong Kong · Delayed Price · Currency is HKD 0.0770
-0.0030 (-3.75%)
Oct 9, 2026, 2:46 PM HKT
HKG:0858 Revenue
In the fiscal year ending March 31, 2026, Extrawell Pharmaceutical Holdings had annual revenue of 51.48M HKD, down -7.12%. Extrawell Pharmaceutical Holdings had revenue of 23.47M in the half year ending March 31, 2026. That makes Extrawell Pharmaceutical Holdings the 39,014th largest company in the world by revenue and 2,385th in Hong Kong.
Revenue
51.48M
Revenue Growth
-13.84%
P/S Ratio
4.34
Revenue / Employee
325.83K
Employees
158
Market Cap
223.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 51.48M | -3.95M | -7.12% |
| Mar 31, 2025 | 55.43M | -3.67M | -6.21% |
| Mar 31, 2024 | 59.10M | -13.48M | -18.57% |
| Mar 31, 2023 | 72.58M | -1.35M | -1.82% |
| Mar 31, 2022 | 73.93M | -4.88M | -6.19% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.90B |
| Lee's Pharmaceutical Holdings | 1.54B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.05B |
| Kontafarma China Holdings | 845.33M |
| Wai Yuen Tong Medicine Holdings | 683.44M |
| Tianda Pharmaceuticals | 350.53M |
| PuraPharm Corporation | 323.49M |
| Fusen Pharmaceutical Company | 318.79M |
Extrawell Pharmaceutical Holdings News
- 9 months ago - Extrawell Pharmaceutical CEO Xie Yi To Resign, Guo Yi To Be New CEO - Nasdaq